Recent posts

Skin Lightening Products: Are They Cosmetics or Drugs?

By October 13, 2017

You won’t like what we found when we tested skin lightening cosmetics that we purchased online.

Categories: Chemical
Tags: , , , , , , , , ,

Building a Perfect Purification Platform

By February 28, 2017

Choosing the right technology is crucial – so it’s great when innovation makes the decision clear-cut. With Gerard Rosse, Associate Director, Structure Guided Chemistry at Dart NeuroScience.

Categories: Customer Stories, Technologies
Tags: , , , , ,

Trailblazing Mass Detection with a New Kind of Innovation

By February 16, 2017

What are the challenges when translating complexity into simplicity – and how do we measure success in such an endeavor? Daniel Kenny, Director of MS Development at Waters, shares the motivation, inspiration and celebration behind… Read more >

Categories: Technologies
Tags: , ,

Changing the Rules with Mass Detection

By February 13, 2017

With access to multiple mass spectrometry systems of varying degrees of sophistication, Davy Guillarme (University of Geneva, Switzerland) wasn’t actively looking for new mass detection solutions. Nevertheless, the Waters ACQUITY QDa mass detector caught his eye.

Categories: Technologies
Tags: , , , ,

Ultra-Pure Proof with Mass Detection

By February 6, 2017

At Reach Separations, they’re putting robust detection on the front lines of method development and mass confirmation.

Categories: Customer Stories, Technologies
Tags: , , , ,

Mission Improbable: Rapid Total Sugar Reporting

By January 31, 2017

How mass detection allows us to tell the beautiful truth about beer By Larissa Burns, Group Technical Analyst, Lion Co.   I’ve been working at Lion as their analytical specialist for eight years, predominantly using… Read more >

Categories: Technologies
Tags: , ,

Mass detection and mAb QC: How a cost-effective and robust peptide mapping method confirms CDR peptides – and can be validated

By March 15, 2016

The quality issues of biopharmaceutical therapeutics are definitely different from chemical drugs because of the increased complexity of manufacturing processes and complexity of the biologic molecules themselves. There is an increasing need for detailed product… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , ,

3 Reasons for Biopharmaceutical Labs to Add Mass Detection to Routine Analyses

By March 9, 2016

As regulators focus in on the critical quality attributes (CQAs) of biotherapeutics, what can biopharmaceutical labs in late development or QC do to increase confidence in their bioseparations assays – other than to run additional… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , ,

Multiple Attribute Monitoring of Biopharmaceuticals Using Mass Detection

By September 3, 2015

Multiple attribute monitoring has become a hot topic of discussion within biopharmaceutical organizations as the methodology allows detection and measurement of more critical quality attributes than conventional methods. Waters recently sponsored an outstanding webinar on… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Screening for Melamine, Cyanuric Acid, and Dicyandiamide in Powdered Milk and Infant Formula

By June 22, 2015

Melamine and cyanuric acid (CA) are low mass, nitrogen-rich compounds that have been linked to protein adulteration in various foodstuffs in the past.1 While melamine and cyanuric acid are not individually toxic, in combination they can… Read more >

Categories: Food, Technologies
Tags: , , , ,